Investor Alert - TRTC Revenues Stock- Price !! INVESTOR

New Post Public Reply Private Reply Replies (0) Message Board
cb11
Investor Alert - TRTC Revenues Stock- Price !!

INVESTOR ALARM ( Ver. Sept. 17th )



Bio·Vegetable & Marijuana-Hemp & Green Tech - TRTC Terra Tech Corp. - USA

( Also Medical Field )



This as attempt for by mutual consent and systematical manner

All Here once to be Agree on same Revenues or Stock- Price

Estimate numbers, because everybody just coming- up with

something different is only causing confusions and really

nothing for the GOOD we need to Relay On !





1. Up-Front lets be Agree on the Stock EPS- Ratios & Earning Definition :

- Blue- Chips have an EPS- Ratio of 10 - 20x , OK !

- None Blue- Chips have an EPS- Ratio of 30 - 60x , OK !

- TRTC as No Blue- Chip to apply middle EPS- Ration of 45x !

- TRTC Stocks instead as Issued & Outstanding 88 Mn take 100 Mn !

( OTC Markets Registered Free- Floating Stocks of 48 Mn, same as 2012 )

- Revenue is Not Earning and Earning is the Margin Not Net- Income

and Net- Income Is after Deductions of Any Expenses from Earning

and before of Any Taxes !





2. For Annual Revenues & Earning to calculate we have TRTC Information’s as :



- 5-Acre Production Plant Revenue $ 10 Mn - we apply 9 Mn by Margin 40 % !

( This also as model to sell High- Tech Companies to US Farming Industry. )



- Contracts with NB Plants of 100% & GroRite of 50% From Its Productions !

NB & GroRite Contracts grant TRTC a Royalty of 10% from its Revenues,

the complain send TRTC to increase this to at least 20% since any Agency

Royalty Standards are between 30 - 60% depending on Items- Price Range.

Wondering when the Vande Vredes will be more reasonable to allow the

Royalty of 20%, but resulting we now need to calculate by 10% only.

From NB Plants is known Revenues $ 6 Mn and GroRite $ 4 Mn, by the

Contracts % Resulting to $ 8 Mn, but we take $ 7 Mn to calculate !



- We have now the Starting Q2 of 65 Days Edible Garden Corp. participation

resulting to $ 0,665 Mn, taking this for the Quarters of usually 90 Days

would result to $ 0,920 Mn, but until now we have no TRTC reply of why

its Estimate Q2 for 65 Days of $ 0,8 Mn was not achieved and therefore

it becomes difficult to use the numbers for calculations !


- Florida Project of Revenue $ 800,000 , where TRTC get a Royalty of 15%,

the complain for after the first Business- Year to increase this also to 20%

is made to TRTC, but since there is not yet any TRTC reconfirmation we

need to calculate this by the Royalty of 15% !



- For the Hydroponic Equipments & Accessories & Companies Sales

we have not any reliable Estimate Numbers and need to wait until

the next Version of Investors Presentation.

Therefore at the moment we cannot consider this !



- For TRTC’s Electricity Management Matter we have also No Numbers

until now and therefore cannot consider this !



This Above Points 1. and 2. As Calculation Basis !!





According to Above and to make it a little more simple,

the Calculation Estimates of Revenue, Earnings and

Stock- Price only as from 2014 :



- New 5-Acre Production Plant, Revenue $ 9 Mn, Earning $ 3,6 Mn !



- NB Plants & GroRite Contracts, Revenue $ 7 Mn, Earning $ 0,7 Mn !



- Florida Project, Revenue $ 0,8 Mn, Earning $ 0,12 Mn !

( Here Without New Such Projects TRTC Announced For US Wide ! )



- Hydroponic Equipments & Accessories & Complete Companies Sales also

under Contracts for Edible Garden Products as in Florida, here not considered !



- The TRTC’s Electricity Management Matter, here not considered !



( Here Without Any MJ or Hemp Growing Projects Soon Possible ! )



As Resulting :

2014 Revenue Estimate = $ 16,8 Mn

2014 Earning Estimate = $ 4,42 Mn



TRTC Stock- Price = $ 1,99 at for example 100 Mn Stocks by EPS- Ratio 45x !!

This within the first 6 Months of 2014, depending on TRTC Progress

Information’s and the resulting Investors Reactions !!



At during 2012 until Q1 2013, the Monthly Money Net- Loss

was at $ 0,5 Mn and this now by 50% Less has improved !.

At Same Rate TRTC Will Be Writing Black- Profit Numbers

Already As From Within November 2013 !!


3. If TRTC by the US Fed. would be allowed to grow MJ or TRTC does

Grow the Gene Manipulated CBD Hemp with ZERO THC as already by

the US Senate as Industrial Agricultural Product Is US Wide Legalized,

it compare the Bio·Vegetable & Herbs could provide a 7 - 10x Higher

Profit- Margin resulting the Stock- Price of $ 1,99 to increase 6 - 8x !!



To use possibly Morphine- Based Medication with Huge- Side- Effects only

for Last Days of Life, because CBD can replace over 90 % of Morphine

Pain- Therapy Applications, beside its potential to reduce Cancer, Etc. !

For TRTC because there is no other same US company existing it means

also, if GW Pharmaceuticals owned by the Big Companies Consortium of

worldwide annual Revenues $ 160 Bn is deciding to have Production of

CBD Sativex also in the US as well for Latin America Markets, it could by

TRTC in US get the Gene Manipulated CBD Hemp produced Hydroponically

Free Of Very Toxic Pesticides, instead now just everything Europe Made !!



Depending on US MJ Laws, TRTC has the Big Potential to become

„King of Marijuana“ because has the capacity to produce the MMJ

in the Best Med. Bio-Quality for the complete US Demand without

Very Toxic Pesticides as by any other much smaller producers !!

This By TRTC‘s Office for MJ & CBD Marketing In Washington !

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IBM's Sports Tech Challenge Crowns AI Innovator LivXP

Updated Category News Views 18

Pioneering AI for Fan Engagement The big leagues of sports tech are buzzing, as IBM has just announced LivXP as the standout winner of their Sports Tech Startup Prize Challenge at the dynamic Web Summit Lisbon 2026. If there's one thing to remember, it's that this isn't just any accolade. This is a nod from IBM—an institution that's rubbed elbows with the giants of...

Continue Reading
Skilled Nursing: The Backbone of Comprehensive Care

Updated Category News Views 17

Crucial Crossroads: Hospital to Home Some stories don't come with ticker symbols or stock rises. Sometimes, we're sifting through what really matters—like Terry Esterline's rundown on skilled nursing and rehab services in Hillsdale, Michigan. This isn't about making a quick buck, it's about what helps people rebuild after a hospital stay. The Nuts and Bolts of Skilled...

Continue Reading
Nauticus Schedules 2026 Q3 Earnings Call; Key Insights Await

Updated Category News Views 100

Word on the street is that Nauticus Robotics is gearing up to dish out their third quarter earnings on November 17, 2026. If you're eyeballing the stock, NASDAQ:KITT, this might be your show. Autonomy in the subsea world isn't just about flashy tech—it's about getting investors to buy into the vision. These folks are turning waves into action with robots that perform...

Continue Reading
HLTH 2026: AI's Role in Couples Therapy Unveiled

Updated Category News Views 14

Testing AI's Place in the Therapy Room AI's getting more action in therapy sessions than it ever dreamed, and it’s high time we asked who benefits and who loses. Slotting in next to human therapists, AI like OurRitual’s Ora isn't about to steal the whole show, but it sure knows how to play a supporting role. At the HLTH 2026 conference, Dr. Orna Guralnik and OurRitual...

Continue Reading
DAN, GPRO, PSNL Deals Under Investor Scrutiny

Updated Category News Views 266

Behind the Curtain: What Do These Deals Mean for Shareholders? Sometimes, investing in a stock ain't just about numbers on a screen—it's about untangling the whole messy ball of yarn these companies hand you with a smile. We're looking at Dana Incorporated (NYSE: DAN), GoPro, Inc. (NASDAQ: GPRO), and Personalis, Inc. (NASDAQ: PSNL). They've all got deals on the table,...

Continue Reading
Baidu Faces Securities Suit Deadline This Week

Updated Category News Views 74

Deadline Looms Large for Baidu Investors Well, here we are again, dealing with another securities class action. If you've got your money parked in Baidu (NASDAQ:BIDU), the clock is ticking, and it's time to pay attention. November 13, 2026, is creeping up fast, and that could be a serious point of no return. What's the Buzz About? Faruqi & Faruqi, LLP, a heavyweight in...

Continue Reading
FIS Under Investigation: Legal Woes Hit Shareholders

Updated Category News Views 55

When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...

Continue Reading
Millrose Faces Class Action for Alleged Deception

Updated Category News Views 124

A Surprising Turn for Millrose Properties Nobody's grumbling over their coffee as much as Millrose Properties' investors these days. The company, traded under NYSE:MRP, is facing a securities class action lawsuit that'll make even the steeliest fund managers flinch. You see, this isn't just any lawsuit—it's a slap in the face of those who thought they were backing a...

Continue Reading
Frasle Mobility's Resilience Despite Market Woes in 3Q26

Updated Category News Views 125

Economic Wrangling: What Happened? Here comes Frasle Mobility, standing tall against a tide trying to pull everyone under. Ending the third quarter of 2026, they dropped a modest net revenue of R$1.38 billion. A light dip of 1.9% year-over-year, but don't let that fool you. Amid the chaos, these folks managed to expand their gross margin and kept their financials...

Continue Reading
MY DR NOW Challenges 9-to-5 with New Clinics

Updated Category News Views 12

Revolutionizing Healthcare Access Latte in one hand and the other hand tapping your steering wheel, trying to squeeze in that elusive doctor’s appointment between work meetings. Sound familiar? Well, those days might just be numbered. MY DR NOW is shaking up the traditional 9-to-5 doctor’s office stereotype by opening two new clinics that’ll stand sentinel seven...

Continue Reading

Top 5 Most Recently Viewed Articles

Immunocore Unveils Promising Data for Brenetafusp in Ovarian Cancer

Updated Category News Views 129

Immunocore Takes Key Steps with Brenetafusp Immunocore, a biotechnology firm dedicated to creating innovative immunomodulating treatments, has revealed important findings from the Phase 1 trials of brenetafusp, an ImmTAC bispecific that targets PRAME in ovarian cancer patients who are resistant to platinum therapy. These results were shared at a notable medical...

Continue Reading
Santhera and Ikris Pharma Join Forces for AGAMREE® in India

Updated Category News Views 216

Santhera Partners with Ikris for AGAMREE® Distribution Pratteln, Switzerland – Santhera Pharmaceuticals (SIX: SANN) has recently formed a pivotal agreement with Ikris Pharma Network to distribute AGAMREE® (vamorolone) in India. This exclusive partnership is dedicated to providing a treatment option for Duchenne muscular dystrophy (DMD) in children four years and...

Continue Reading
Orchid Island Capital Highlights August Dividend and Portfolio Insights

Updated Category News Views 183

Orchid Island Capital Declares August Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC), a prominent player in the specialized finance sector, has declared a monthly cash dividend of $0.12 per common share for August. This dividend is scheduled for distribution on September 29, keeping with the company’s commitment to returning value to its shareholders. Dividend...

Continue Reading
Mercari Japan App Debuts in U.S.: A Shopping Shift

Updated Category News Views 15

A New Frontier for Cross-Border Shopping There's a fresh wind blowing for collectors and Japan enthusiasts in the U.S. as Mercari Japan rolls out a new standalone app on American soil. Designed to streamline the hunt for Japanese treasures, it’s a bold play to solidify Mercari’s position as a cross-border e-commerce powerhouse. Maybe they’ve seen the writing on the...

Continue Reading
Franklin Access Receives Financing for Groundbreaking Sigbeat Venture

Updated Category News Views 195

Franklin Access Secures New Funding for Innovative Sigbeat Joint Venture Franklin Access (NASDAQ: FKWL) is thrilled to announce that it has successfully secured funding for its strategic joint venture to develop cutting-edge 4G/5G modules and artificial intelligence (AI) solutions under the Sigbeat brand. This significant milestone marks a transformative step towards...

Continue Reading